sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
sarscov
affect
peopl
produc
death
countriesregion
vital
step
prevent
control
futur
epidem
block
transmiss
infect
effect
quarantin
polici
turn
hing
earli
diagnosi
confirm
diseas
particularli
laboratori
test
need
rapid
ultrasensit
assay
detect
infect
earli
cours
diseas
obviou
antibodi
respons
sarscov
infect
detect
day
ill
henc
earli
laboratori
diagnosi
rest
earli
detect
viru
detect
reli
revers
transcript
follow
pcr
rtpcr
design
realtim
quantit
rtpcr
assay
sarscov
use
taqman
probe
instead
probe
hybrid
pcr
product
improv
sensit
simpl
modif
use
dual
taqman
probe
quantif
wide
applic
area
ultrasensit
critic
requir
assay
design
amplifi
region
sarscov
taqman
ez
rtpcr
kit
real
time
pcr
system
appli
biosystem
compar
assay
use
taqman
probe
fig
b
reaction
mixtur
contain
taqman
ez
buffer
mm
manganes
acet
mm
deoxynucleotid
triphosph
except
mm
dutp
u
amperas
ung
u
rtth
dna
polymeras
primer
probe
extract
rna
assay
assay
base
previou
report
slight
modif
reaction
start
incub
min
follow
revers
transcript
min
denatur
min
amplif
compris
cycl
min
calibr
prepar
concentr
rna
stock
extract
sarscov
cultur
qiaamp
viral
rna
mini
kit
qiagen
quantifi
realart
hpacoronaviru
lc
rtpcr
kit
artu
public
health
laboratori
centr
notempl
control
includ
run
expect
final
fluoresc
intens
twice
high
threshold
cycl
number
ct
smaller
dualprob
assay
fig
assay
fig
given
input
rna
copi
number
per
reaction
fig
c
comparison
made
basi
copi
number
per
reaction
account
differ
input
rna
volum
assay
moreov
calibr
contain
rna
copi
per
reaction
detect
time
dualprob
assay
time
assay
fig
improv
sensit
attribut
chang
forward
primer
contrari
assay
fig
use
forward
primer
probe
hardli
detect
calibr
contain
copi
per
reaction
although
gave
calibr
curv
almost
overlap
fig
simpl
modif
use
dual
probe
instead
probe
increas
sensit
assay
investig
effect
assay
probe
hybrid
complementari
target
strand
strand
dualprob
assay
probe
hybrid
complementari
strand
assay
antisens
probe
hybrid
sens
target
strand
wherea
sens
probe
assay
hybrid
antisens
target
strand
fig
assay
gave
result
assay
seri
calibr
use
thu
cleavag
effici
assay
sensit
affect
whether
probe
cleav
polymeras
molecul
assay
differ
polymeras
molecul
assay
given
pair
complementari
target
strand
singl
cycl
turn
allow
flexibl
probe
design
even
within
short
stretch
sequenc
provid
probe
hybrid
analyz
archiv
rna
sampl
sar
case
confirm
outbreak
extract
stool
collect
day
onset
ill
nasopharyng
aspir
day
onset
serum
day
onset
rna
sampl
previous
assay
artu
assay
concentr
per
ml
rna
sampl
public
health
laboratori
centr
test
posit
dualprob
assay
concentr
per
ml
rna
sampl
fig
suggest
dualprob
assay
least
sensit
artu
assay
could
detect
sarscov
clinic
specimen
collect
earli
day
diseas
onset
evalu
specif
dualprob
assay
analyz
rna
sampl
extract
confirm
case
influenza
n
noroviru
n
human
coronavirus
sampl
test
neg
improv
rna
extract
method
detect
limit
copi
per
rtpcr
reaction
common
studi
report
limit
detect
copi
per
reaction
addit
nest
pcr
step
rtpcr
allow
detect
copi
per
reaction
much
reduc
dynam
detect
rang
use
taqman
probe
instead
increas
assay
sensit
without
compromis
dynam
detect
rang
even
assay
detect
limit
copi
per
reaction
specul
dualprob
strategi
increas
signal
strength
henc
assay
reproduc
low
detect
rang
use
taqman
probe
label
differ
report
dye
singl
pcr
qualit
purpos
allel
discrimin
well
establish
allelespecif
probe
hybrid
allelespecif
amplicon
nonallel
amplicon
far
awar
first
report
describ
use
taqman
probe
label
report
dye
hybrid
amplicon
quantif
purpos
increas
sensit
quantit
assay
per
se
obvious
strategi
applic
rna
dna
input
templat
simpl
modif
also
appli
mani
area
ultrasensit
earli
detect
target
nucleic
acid
utmost
import
eg
infect
sar
one
exampl
tumor
increas
assay
sensit
would
counteract
dilut
effect
pool
donor
plasma
nucleic
acid
test
screen
transmiss
infecti
agent
blood
donat
quantif
residu
tumor
cell
eg
leukem
cell
earli
remiss
requir
sensit
assay
limit
amount
target
sequenc
also
encount
paraffinembed
tissu
block
ancient
specimen
forens
specimen
taken
crime
scene
circul
nucleic
acid
engraft
sexmismatch
organ
transplant
preliminari
data
indic
use
probe
enhanc
assay
sensit
rather
increas
variabl
duplic
read
hand
worth
investig
whether
dualprob
strategi
quantif
purpos
extend
molecular
beacon
hybrid
probe
conclus
report
use
dual
taqman
probe
quantif
purpos
appli
detect
sarscov
detect
limit
copi
rna
per
reaction
strategi
expect
applic
mani
area
requir
ultrasensit
andor
earli
detect
target
sequenc
